Creative Enzymes is proud to announce the launch of Recombinant Porcine Citrate Synthase (28-464aa) with an optimized C-His Tag, which is poised to revolutionize research in cellular metabolism, bioenergetics, and a wide range of life science applications.

Shirley, New York, United States - May 27, 2024 —

Creative Enzymes, a renowned supplier of high-purity enzymes, is proud to announce the launch of its latest innovation - Recombinant Porcine Citrate Synthase (28-464aa) with an optimized C-His Tag. This cutting-edge enzyme is poised to revolutionize research in cellular metabolism, bioenergetics, and a wide range of life science applications.

Citrate synthase is a pivotal enzyme in the tricarboxylic acid (TCA) cycle, playing a crucial role in cellular energy production. The recombinant porcine citrate synthase offered by Creative Enzymes is engineered with a strategically placed C-terminal histidine tag, which streamlines the purification process and simplifies detection for researchers.

"Our team of experienced enzymologists has meticulously designed this product to address the evolving needs of the scientific community," said the spokesperson for Creative Enzymes. "The enhanced C-His tag on our recombinant porcine citrate synthase provides researchers with unparalleled convenience and reliability in their studies of metabolic pathways and energy metabolism."

One of the key advantages of Creative Enzymes' Recombinant Porcine Citrate Synthase is its exceptional purity and specific activity. Leveraging advanced chromatographic techniques and stringent quality control measures, the company ensures that each batch of the enzyme delivers consistent performance, allowing researchers to trust their results and focus on their core objectives.

"The C-His tag on the recombinant porcine citrate synthase from Creative Enzymes is a game-changer for researchers working in the field of cellular metabolism," said the senior scientist. "The tag simplifies the purification process, enabling us to rapidly isolate the enzyme with high purity. This, in turn, enhances the reliability and reproducibility of our experiments, ultimately accelerating our understanding of energy production pathways in cells."

Whether you are investigating the role of citrate synthase in disease mechanisms, optimizing biofuel production, or exploring the intricacies of mitochondrial function, this enzyme from Creative Enzymes is a powerful tool that can propel your research forward.

In addition to its technical advantages, the Recombinant Porcine Citrate Synthase (28-464aa) with C-His Tag from Creative Enzymes is designed with user-friendliness in mind. The enzyme is available in a range of convenient pack sizes, catering to the diverse needs of laboratories of all scales. Customers can easily place orders through the company's intuitive online platform, ensuring a seamless purchasing experience.

"At Creative Enzymes, we are committed to empowering researchers with the most advanced and reliable tools to drive scientific progress," he added. "Our Recombinant Porcine Citrate Synthase with the enhanced C-His Tag is a testament to this dedication, and we are excited to see how it will contribute to groundbreaking discoveries across multiple disciplines."

About Creative Enzymes

Creative Enzymes is a leading provider of high-purity enzymes for life science research and industrial applications. With a focus on innovation and customer satisfaction, the company leverages its expertise in enzyme manufacturing to deliver cutting-edge solutions that empower researchers and drive progress in various fields.

Contact Info:
Name: Iva Colter
Email: Send Email
Organization: Creative Enzymes
Website: https://www.creative-enzymes.com/

Release ID: 89131037

In the event of encountering any errors, concerns, or inconsistencies within the content shared in this press release, we kindly request that you immediately contact us at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will be readily accessible to address your feedback within 8 hours and take appropriate measures to rectify any identified issues or facilitate press release takedowns. Ensuring accuracy and reliability are central to our commitment.